SCHEMBL10036554

SCHEMBL10036554

O=C(Cl)c1ccc(-c2ccc(COCl)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 1/20 0.42
NR4A2 P43354 2/20 0.41
PTPRC P08575 1/20 0.41
PTPN2 P17706 1/20 0.41
PTPN1 P18031 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAOB P27338 2/20 0.40
MAOA P21397 1/20 0.40
RXRA P19793 5/20 0.39
RXRB P28702 5/20 0.39
HPGD P15428 1/20 0.39
SMPD1 P17405 2/20 0.39
GLRA1 P23415 1/20 0.39
MAPT P10636 1/20 0.38
FFAR1 O14842 1/20 0.38
RXRG P48443 1/20 0.38
BCL2L1 Q07817 2/20 0.38
MCL1 Q07820 2/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10036561 0.94 PARP10 (0.46) PARP10NR4A2PTPRCPTPN2PTPN1
SCHEMBL10036584 0.89 KMT2A (0.45) PARP10NR4A2PTPRCPTPN2PTPN1
SCHEMBL10036580 0.89 HTT (0.45) PARP10NR4A2PTPRCPTPN2PTPN1
SCHEMBL10036583 0.85 PARP10 (0.47) PARP10NR4A2PTPRCPTPN2PTPN1
SCHEMBL12671969 0.84 RAB9A (0.53) PARP10NR4A2PTPRCPTPN2PTPN1
SCHEMBL10036590 0.82 ALDH1A1 (0.41) PARP10NR4A2PTPRCPTPN2PTPN1
SCHEMBL10036585 0.81 RXRA (0.47) NR4A2MEN1KMT2AMAOBMAOA
SCHEMBL12696220 0.79 MAOB (0.43) NR4A2PTPRCPTPN2PTPN1MAOB
SCHEMBL10670934 0.78 ALDH1A1 (0.52) PTPN1MEN1KMT2ARXRARXRB
SCHEMBL727046 0.78 ALDH1A1 (0.52) PTPN1MEN1KMT2ARXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120241373-A1 COMPOSITE MEMBRANES AND METHODS OF PREPARATION THEREOF INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2012-09-27 US disclosed
US-20120012527-A1 COMPOSITE MEMBRANE WITH MULTI-LAYERED ACTIVE LAYER INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2012-01-19 US disclosed
US-20100216899-A1 POLYAMIDE MEMBRANES WITH FLUOROALCOHOL FUNCTIONALITY INTERNATIONAL BUSINESS MACHINES CORPORATION 2010-08-26 US disclosed
WO-2010096563-A1 POLYAMIDE MEMBRANES WITH FLUOROALCOHOL FUNCTIONALITY INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2010-08-26 WO disclosed
US-20100216967-A1 INTERFACIAL POLYMERIZATION METHODS FOR MAKING FLUOROALCOHOL-CONTAINING POLYAMIDES INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2010-08-26 US disclosed
US-20080070850-A1 GALLOTANNINS AND ELLIGITANNINS AS REGULATORS OF CYTOKINE RELEASE THE PENN STATE RESEARCH FOUNDATION (US) 2008-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070850-A1 GALLOTANNINS AND ELLIGITANNINS AS REGULATORS OF CYTOKINE RELEASE IL2, IL6, TNF PARP10 3984/4885NR4A2 3441/4885PTPRC 677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.